Methylation profiling defines an extensive field defect in histologically normal prostate tissues associated with prostate cancer

Bing Yang, Sachin Bhusari, Jessica Kueck, Pushpa Weeratunga, Jennifer Wagner, Glen Leverson, Wei Huang, David F. Jarrard

Research output: Contribution to journalArticle

34 Scopus citations


Prostate cancer (PCa) is typically found as a multifocal disease suggesting the potential for molecular defects within the morphologically normal tissue. The frequency and spatial extent of DNA methylation changes encompassing a potential field defect are unknown. A comparison of non-tumor-associated (NTA) prostate to histologically indistinguishable tumor-associated (TA) prostate tissues detected a distinct profile of DNA methylation alterations (0.2%) using genome-wide DNA arrays based on the Encyclopedia of DNA Elements 18 sequence that tile both gene-rich and poor regions. Hypomethylation (87%) occurred more frequently than hypermethylation (13%). Several of the most significantly altered loci (CAV1, EVX1, MCF2L, and FGF1) were then used as probes to map the extent of these DNA methylation changes in normal tissues from prostates containing cancer. In TA tissues, the extent of methylation was similar both adjacent (2 mm) and at a distance (>1 cm) from tumor foci. These loci were also able to distinguish NTA from TA tissues in a validation set of patient samples. These mapping studies indicate that a spatially widespread epigenetic defect occurs in the peripheral prostate tissues of men who have PCa that may be useful in the detection of this disease.

Original languageEnglish (US)
Pages (from-to)399-408
Number of pages10
JournalNeoplasia (United States)
Issue number4
StatePublished - Apr 2013


ASJC Scopus subject areas

  • Cancer Research

Cite this